Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling

被引:26
作者
Bridges, John F. P. [1 ]
Beusterien, Kathleen [2 ]
Heres, Stephan [3 ]
Such, Pedro [4 ]
Sanchez-Covisa, Joaquin [5 ]
Nylander, Anna-Greta [4 ]
Chan, Elcie [6 ]
de Jong-Laird, Anne [5 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[2] Outcomes Res Strategies Hlth, Albemarle St NW, Washington, DC 20008 USA
[3] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[4] H Lundbeck A S, Global Med Affairs, Valby, Denmark
[5] Otsuka Pharmaceut Europe Ltd, Med Dept, Wexham, England
[6] Otsuka Pharmaceut Europe Ltd, HEOR Market Access, Wexham, England
来源
PATIENT PREFERENCE AND ADHERENCE | 2018年 / 12卷
关键词
recent-onset schizophrenia; preferences; treatment goals; PREFERENCES; BURDEN; ONSET; ANTIPSYCHOTICS; DISORDERS; BRAIN; AGE;
D O I
10.2147/PPA.S152870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study seeks to quantify the treatment goals of people recently diagnosed with schizophrenia and explore their impact on treatment plan. Methods: People aged 18-35 years with a confirmed diagnosis of schizophrenia within the past 5 years were surveyed in the UK, Germany, and Italy. Treatment goals were assessed via a validated best-worst scaling instrument, where participants evaluated subsets of 13 possible treatment goals identified using a balanced incomplete block design. Participants identified the most and least important goals within each task. Data were also collected on current treatment and preference for daily oral versus long-acting injectable (LAI) treatment. Hierarchical Bayes was used to identify preference weights for the goals, and latent class analysis was used to identify segments of people with similar goals. The segments were compared with the current treatment and preference for oral versus LAI treatment. Results: Across 100 participants, the average age was 26 years, 75% were male and 50% were diagnosed within 2 years ago. Overall, preferences were most favorable for reduced disease symptoms, think clearly, reduced hospitalizations, reduced anxiety, and take care of self. A total of 61% preferred oral medication and 39% LAI. Two groups were identified with different treatment goals; 50% of participants emphasized clinical goals, including reduced disease symptoms (preference weight = 19.7%), reduced hospitalizations (15.5%), and reduced anxiety (10.5%). The other 50% emphasized functional goals, including improved relationships with family/friends (11.4%), increased interest in work (10.6%), experiencing a fuller range of emotions (8.4%), and ability to socialize (7.5%). Those emphasizing functional goals were more likely to be on LAI (44% versus 26%; p=0.059) and preferred LAI (46% versus 32%; p=0.151). Conclusions: People with recent-onset schizophrenia may focus more on clinical goals or functional goals, a discussion of which may help facilitate patient engagement.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 50 条
  • [41] Exploring tourist preferences for local food: a Best-Worst Scaling analysis and market segmentation approach
    Tiganis, Antonios
    Chrysochou, Polymeros
    BRITISH FOOD JOURNAL, 2024, 126 (12): : 4093 - 4107
  • [42] Parents and adolescents preferences for asthma control: a best-worst scaling choice experiment using an orthogonal main effects design
    Wendy J. Ungar
    Anahita Hadioonzadeh
    Mehdi Najafzadeh
    Nicole W. Tsao
    Sharon Dell
    Larry D. Lynd
    BMC Pulmonary Medicine, 15
  • [44] Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria
    Feig, Chiara
    Cheung, Kei Long
    Hiligsmann, Mickael
    Evers, Silvia M. A. A.
    Simon, Judit
    Mayer, Susanne
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (02) : 223 - 232
  • [45] Best-Worst Scaling to Prioritize Outcomes Meaningful to Caregivers of Youth with Mental Health Multimorbidities: A Pilot Study
    Castillo, Wendy Camelo
    Ross, Melissa
    Tariq, Saad
    dosReis, Susan
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2018, 39 (02) : 101 - 108
  • [46] The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach
    Wranik, Wieslawa Dominika
    Szekely, Ronaldo-Raul
    Mayer, Susanne
    Hiligsmann, Mickael
    Cheung, Kei Long
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 846 - 856
  • [47] Comparing results of ranking conjoint analyses, best-worst scaling and discrete choice experiments in a nonhypothetical context
    Yangui, Ahmed
    Akaichi, Faical
    Costa-Font, Montserrat
    Maria Gil, Jose
    AUSTRALIAN JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS, 2019, 63 (02) : 221 - 246
  • [48] A best-worst scaling survey of medical students' perspective on implementing shared decision-making in China
    Xu, Richard Huan
    Zhou, Lingming
    Wong, Eliza Lai-Yi
    Wang, Dong
    Xiang, Guo Chun
    Xu, Chao
    BMC MEDICAL EDUCATION, 2020, 20 (01)
  • [49] Using best-worst scaling choice experiments to elicit the most important domains of health for health-related quality of life in Singapore
    Uy, Elenore Judy B.
    Bautista, Dianne Carrol
    Xin, Xiaohui
    Cheung, Yin Bun
    Thio, Szu-Tien
    Thumboo, Julian
    PLOS ONE, 2018, 13 (02):
  • [50] Consumer demand for urban forest ecosystem services and disservices: Examining trade-offs using choice experiments and best-worst scaling
    Soto, Jose R.
    Escobedo, Francisco J.
    Khachatryan, Hayk
    Adams, Damian C.
    ECOSYSTEM SERVICES, 2018, 29 : 31 - 39